
Oxford+ in Brief with Ceri Morgan, Partner at Dalloway Partners
Susannah de Jager·Oxford, United Kingdom
Dr Ceri Morgan, partner at Dalloway Partners, discusses measuring success in Oxford's science ecosystem, advises newcomers on navigating it, and envisions 2050 with more local scaling and reinvestment.
Listen on

Now playing
Oxford+ in Brief with Ceri Morgan, Partner at Dalloway Partners
Bonus · 16 Jun 2026
Featured
Susannah de JagerHost
Ceri MorganGuest
Production
Matt Eastland-JonesProducer
Story Ninety-FourProduction Company
Show notes
How should we measure success in the place trying to scale Britain's best science?
In this Oxford+ in Brief, Dr Ceri Morgan takes on the same four quick-fire questions every guest faces. She reflects on what success would mean after two decades spent at arm's length in investment banking, the advice she would give anyone entering the Oxford ecosystem, and what the city does brilliantly yet struggles with: it brings you face to face with astonishing, modest people, but connects them far too rarely.
Looking ahead to 2050, Ceri wants Oxford closer to the Boston benchmark, with more companies scaling outside the university and acquirers reinvesting locally rather than draining talent abroad. Her timing is apt: UK university spin-outs have nearly tripled in value to £49 billion since 2020, with activity now spreading beyond the golden triangle. From mentorship and the Lamb and Flag to a magic-wand investor database, this is a short, candid window into how a natural connector thinks.
Ceri Morgan: Dr Ceri Morgan is a Partner at Dalloway Partners, the advisory firm founded in 2025 by Vanessa Colomar and Helen James to help foundational science and first-time founders scale at speed. A medical doctor by training, she practised in cardiology and trauma medicine before moving into the City, where she spent more than two decades in healthcare and life sciences investment banking, building and leading top-ranked life science teams at firms including KBC Peel Hunt and Deutsche Bank and advising companies such as Oxford Nanopore and IP Group. Most recently she was Head of Late Stage Portfolio at Oxford Science Enterprises, and she is a Senior Advisor to LifeScience ORG. Based in Oxford, she also sits on a London hospital patient advisory group, drawing on her own experience as a cancer patient to push for stronger patient advocacy.
Susannah de Jager: Susannah is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital.
Connect with Susannah on LinkedIn and Subscribe to the Oxford+ Newsletter for Exclusive Content
Oxford+ is hosted by Susannah de Jager and supported by Mishcon de Reya, HSBC Innovation Banking, and James Cowper Kreston.
Produced and Edited by Story Ninety-Four in Oxford.
Transcript
Partners
mishcon.comIn partnership with
Mishcon de Reya
The Mishcon de Reya Group is an independent, international professional services business with law at its heart, employing over 1450 people with over 650 lawyers. It includes the law firm Mishcon de Reya LLP and a collection of leading consultancy businesses that complement the firm's legal services.
oxfordequinox.comSponsored by
Equinox
Equitable Innovation Oxford is a major regional partnership established by the University of Oxford to drive inclusive innovation and sustainable economic growth locally, nationally and globally. Equinox serves as a voice for the region, championing innovation that delivers economic impact and social value.